INTERVENTIONALPROTOCOL REGISTERED2022-000271-39

Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD)

Tardive dyskinesia

Locally preserved from EU Clinical Trials Register (EudraCT)Open EU Clinical Trials Register (EudraCT)last source update not reported

What this record can show

Protocol only - no registry results posted

This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.

Registry facts

Linked local records

Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.

No published condition report matched.

No governed compound link was found.

No exact medicine-name link was found.

Interventions

No structured intervention was reported.

Eligibility

No structured eligibility criteria were reported.

Publications

No exact PMID-linked public article is currently readable locally.

Snapshot provenance